Stan Berenshteyn
Stock Analyst at Wells Fargo
(0)
# 3349
Out of 5,231 analysts
60
Total ratings
46.43%
Success rate
3.23%
Average return
Main Sectors:
Top Industries:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
Health Catalyst | Maintains: Overweight | 13 10 | 5.66 | 76.68% | 5 | Jan 21, 2025 | |
Omnicell | Maintains: Equal-Weight | 49 40 | 44.69 | -10.49% | 12 | Jan 13, 2025 | |
Doximity | Maintains: Equal-Weight | 41 43 | 57.74 | -25.53% | 9 | Jan 13, 2025 | |
American Well | Upgrades: Overweight | 15 15 | 10.99 | 36.49% | 3 | Jan 13, 2025 | |
Veeva Systems | Maintains: Overweight | 275 285 | 232.71 | 22.47% | 5 | Dec 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 7 6 | 6.87 | -12.66% | 10 | Oct 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 107 110 | 109.04 | 0.88% | 8 | Jun 20, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 10 | 4.86 | 105.76% | 6 | Mar 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 28 23 | 10.37 | 121.79% | 2 | Mar 6, 2023 |